Skip to main content
. 2014 Oct 17;17(3):251–257. doi: 10.1111/hpb.12340

Table 1.

Population demographics and pre-transplant characteristics in 785 liver transplant recipients

Variables Body mass index, kg/m2 P-value
<18.0 (n = 9) 18.0–24.9 (n = 210) 25.0–29.9 (n = 294) 30.0–35.0 (n = 169) 35.1–40.0 (n = 77) >40.0 (n = 26)
Age, years, median 46 55 55 56 56 53 0.349
Male, % 4 (44.4) 134 (63.8) 214 (72.8) 119 (70.4) 47 (61.0) 10 (37.0) 0.001
White, % 7 (0.78) 171 (81.4) 249 (84.7) 148 (87.6) 68 (88.3) 13 (73.1) 0.267
Comorbidities, %
 Diabetes 3 (33.3) 44 (21.0) 76 (25.9) 51 (30.2) 25 (32.5) 6 (23.1) 0.277
 Hypertension 1 (11.1) 49 (23.3) 85 (28.9) 59 (34.9) 31 (40.3) 14 (53.8) <0.0001
 Coronary artery disease 0 (0) 6 (2.9) 20 (6.8) 9 (5.3) 6 (7.8) 2 (7.7) 0.311
 Other cardiac disease 0 (0) 15 (7.1) 26 (8.8) 16 (9.5) 10 (13.0) 3 (11.5) 0.621
 Renal insufficiency 2 (22.2) 27 (12.9) 52 (17.7) 26 (15.4) 19 (24.7) 1 (3.8) 0.089
 Renal failure on dialysis 2 (22.2) 19 (9.0) 23 (7.8) 18 (10.7) 11 (14.3) 2 (7.7) 0.497
Aetiology of liver disease, %
 Hepatitis C virus 3 (33.3) 80 (38.1) 149 (50.7) 78 (46.2) 31 (40.3) 12 (46.2) 0.102
 Non-alcoholic steatohepatitis 0 (0.0) 2 (0.9) 19 (6.5) 14 (8.3) 17 (22.8) 6 (23.1) <0.0001
 Alcohol (primary diagnosis) 4 (44.4) 32 (15.2) 35 (11.9) 21 (12.4) 12 (15.6) 2 (7.7) 0.082
 Alcohol (secondary diagnosis) 0 13 (6.2) 25 (8.5) 14 (8.3) 9 (11.7) 1 (3.8) 0.543
 Primary biliary cirrhosis 0 16 (7.6) 14 (4.8) 4 (2.4) 2 (2.6) 1 (3.8) 0.15
 Primary sclerosing cholangitis 1 (11.1) 18 (8.6) 11 (3.7) 4 (2.4) 1 (1.3) 0 0.012
 Other 1 (11.1) 62 (29.5) 66 (22.4) 48 (28.4) 14 (18.2) 5 (19.2) 0.176
 Hepatocellular carcinoma 0 (0.0) 81 (38.6) 110 (37.4) 61 (36.1) 29 (37.7) 7 (26.9) 0.836
Other
 MELD score, lab-based, median 28 18 19 20 24 23 0.002
 Waiting time, days, median 25 59 59 89 82 72 0.011
 Liver and kidney transplant, % 1 (11.1) 11 (5.2) 13 (4.4) 6 (3.6) 4 (5.2) 0 (0) 0.719

MELD, Model for End-stage Liver Disease.